Seeking Alpha

Peregrine Pharma EPS in-line , misses on revenue

  • Peregrine Pharma (PPHM): FQ1 EPS of -$0.05 in-line.
  • Revenue of $4.68M misses by $0.07M. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs